tenofovir has been researched along with Genital Tract Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cottrell, M; Dellon, ES; Gonzalez, D; Kashuba, ADM; Madanick, RD; Maffuid, K; Nelson, JAE; Prince, HA; Shaheen, NJ; Srinivas, N; Sykes, C; White, N | 1 |
Frieboes, HB; Halwes, ME; Steinbach-Rankins, JM; Tyo, KM | 1 |
Blake, KH; Chen, J; Cohen, MS; Dumond, JB; Gay, CL; Greene, SA; Kashuba, ADM; Maas, BM; Nelson, JAE; Prince, HMA; Schauer, AP; Sykes, C | 1 |
Agrahari, V; Christenson, LK; Dim, DC; Ezoulin, MJ; Hung, WT; Meng, J; Molteni, A; Youan, BC; Youm, I | 1 |
4 other study(ies) available for tenofovir and Genital Tract Infections
Article | Year |
---|---|
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cohort Studies; Computer Simulation; Demography; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Maraviroc; Pre-Exposure Prophylaxis; Reproductive Tract Infections; Tenofovir; Treatment Outcome | 2020 |
Computational Modeling of Antiviral Drug Diffusion from Poly(lactic- co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract.
Topics: Anti-HIV Agents; Computer Simulation; Diffusion; Epithelium; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Polyesters; Reproductive Tract Infections; Reverse Transcriptase Inhibitors; Tenofovir | 2018 |
Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tract.
Topics: Adenine; Anti-Retroviral Agents; Blood Cells; Emtricitabine; Genitalia, Male; HIV Infections; Humans; Leukocytes, Mononuclear; Male; Reproductive Tract Infections; Semen; Tenofovir | 2019 |
Stimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activity.
Topics: Animals; Anti-HIV Agents; Drug Liberation; Female; HIV Infections; Humans; Hyaluronic Acid; Mice; Nanofibers; Reproductive Tract Infections; Sulfhydryl Compounds; Tenofovir; Vagina | 2016 |